Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T04:02:06.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; prior notice about government funding status (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T16:21:45.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and NIH Clinical Center operations was added, and the page now shows a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:45:23.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The updates are minor editorial changes to UI text and versioning, including adding a 'Show glossary' option, correcting capitalization in labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act Data', and updating the revision from v3.3.4 to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T06:37:04.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed. No changes to study content or page functionality.
    Difference
    0.0%
    Check dated 2026-01-14T02:55:40.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing participating states for the Cypress-1 trial (rev. v3.3.3).
    Difference
    2%
    Check dated 2025-12-23T17:06:47.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.